- Home
- LUNG
LUNG
Pulmonx Corporation
as 04-18-2025 1:39pm EST
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | N/A | IPO Year: | 2020 |
| Target Price: | $12.64 | AVG Volume (30 days): | 367.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.72 - $10.01 | Next Earning Date: | 04-30-2025 |
| Revenue: | $83,789,000 | Revenue Growth: | 22.01% |
| Revenue Growth (this year): | 17.97% | Revenue Growth (next year): | 18.88% |
Stock Insider Trading Activity of Pulmonx Corporation (LUNG)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| French Glendon E. III | LUNG | Director | Mar 20 '25 | Sell | $7.85 | 20,000 | $157,000.00 | 991,974 | |
| Joshi Mehul | LUNG | Chief Financial Officer & PAO | Mar 3 '25 | Sell | $7.12 | 14,384 | $102,414.08 | 113,986 | |
| Rose Geoffrey Beran | LUNG | CHIEF COMMERCIAL OFFICER | Mar 3 '25 | Sell | $7.13 | 5,779 | $41,193.02 | 287,295 | |
| Lehman David Aaron | LUNG | GENERAL COUNSEL | Mar 3 '25 | Sell | $7.31 | 22,355 | $170,920.96 | 189,118 | |
| Williamson Steven S. | LUNG | PRESIDENT AND CEO | Mar 3 '25 | Sell | $7.14 | 27,689 | $197,699.46 | 194,342 | |
| French Glendon E. III | LUNG | Director | Feb 20 '25 | Sell | $8.45 | 55,453 | $459,085.96 | 991,974 |
Latest Pulmonx Corporation News
LUNG Breaking Stock News: Dive into LUNG Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025
Zacks
3 days ago
P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar?
Zacks
9 days ago
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last?
Simply Wall St.
2 months ago
Pulmonx Full Year 2024 Earnings: Beats Expectations
Thomson Reuters StreetEvents
2 months ago
Q4 2024 Pulmonx Corp Earnings Call
GuruFocus.com
2 months ago
Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ...
Zacks
2 months ago
Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates
GlobeNewswire
2 months ago
Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results
Compare LUNG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LUNG Pulmonx Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.